Current management of ophthalmic zoster.
Most ophthalmic zoster occurs in healthy people and ocular complications occur in 50%. The mainstay of ocular therapy is topical steroid, but careful follow-up and withdrawal are essential. The place of systemic steroid therapy and acyclovir in immunocompetent patients with zoster is uncertain.
Marsh
R J
RJ
St Mary's Hospital, London, England.
D002387:Cataract Extraction; D003315:Cornea / Q000601:surgery; D005128:Eye Diseases / Q000209:etiology / Q000628:therapy; D005143:Eyelids / Q000601:surgery; D005901:Glaucoma / Q000601:surgery; D006563:Herpes Zoster Ophthalmicus / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology